Global Disruptive Behavior Disorder Treatment Market – Industry Trends and Forecast to 2030

Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista Relatório de amostra grátis Relatório de amostra grátis Consulte antes Comprar Consulte antes  Comprar agora Comprar agora

Global Disruptive Behavior Disorder Treatment Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Reports
  • Jul 2023
  • Global
  • 350 Páginas
  • Número de tabelas: 60
  • Número de figuras: 220

Global Disruptive Behavior Disorder Treatment Market

Tamanho do mercado em biliões de dólares

CAGR :  % Diagram

Chart Image USD 1,381.06 Million USD 2,087.57 Million 2022 2030
Diagram Período de previsão
2023 –2030
Diagram Tamanho do mercado (ano base )
USD 1,381.06 Million
Diagram Tamanho do mercado ( Ano de previsão)
USD 2,087.57 Million
Diagram CAGR
%
Diagram Principais participantes do mercado
  • Lilly Pfizer Inc. Johnson &amp
  • Johnson ServicesInc. Bionomics Highland Ridge Hospital Lakeview Health Boston Children&#39
  • s Hospital Integris Health ST. JOHN Springwoods Behavioral Health. Alliance Health Durant Midwest Health Center Chelsea Therapeutics InternationalLtd. DURECT CORPORATION Jane Phillips Medical Center KVC Health System Mindsbhumika NYU Langone Hospitals Seattle Children&#39
  • s Hospital

Global Disruptive Behavior Disorder Treatment Market, By Type (Conduct Disorder, Intermittent Explosive Disorder, Oppositional Defiant Disorder), Treatment (Social and Emotional Skills Training, Medication Management, Individual Therapy, Comprehensive Evaluation, Family Therapy, Group Therapy, Parenting Modification) – Industry Trends and Forecast to 2030.

 Disruptive Behavior Disorder Treatment Market

Disruptive Behavior Disorder Treatments Market Analysis and Size

The prevalence of disruptive behavior disorder statistics is estimated to be 6.1% percent. Oppositional defiant disorder usually develops before the age of 8 and conduct disorder can occur as early as 5 years old (mainly in boys).Data Bridge Market Research analyses that the disruptive behavior disorder treatment market which was USD 1381.06 million in 2022, will reach USD 2087.57 million by 2030, and is expected to undergo a CAGR of 5.3% during the forecast period of 2023 to 2030. "Oppositional Defiant Disorder" dominates the type segment of the Disruptive Behavior Disorder Treatment market owing to the growing demand for better neurological disorder treatment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Disruptive Behavior Disorder Treatments Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, and Pricing in USD

Segments Covered

Type (Conduct Disorder, Intermittent Explosive Disorder, Oppositional Defiant Disorder) and Treatment (Social and Emotional Skills Training, Medication Management, Individual Therapy, Comprehensive Evaluation, Family Therapy, Group Therapy, Parenting Modification)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa

Market Players Covered

Lilly (U.S), Pfizer Inc. (U.S), Johnson & Johnson Services, Inc. (U.S), Bionomics (Australia), Highland Ridge Hospital (U.S), Lakeview Health (U.S), Boston Children's Hospital (U.S), Integris Health (U.S), ST. JOHN (U.K), Springwoods Behavioral Health. (Arkansas), Alliance Health Durant (U.S), Midwest Health Center (U.S), Chelsea Therapeutics International, Ltd. (U.S), DURECT CORPORATION (U.S), Jane Phillips Medical Center (U.S), KVC Health System (U.S), Mindsbhumika (India), NYU Langone Hospitals (U.S), Seattle Children's Hospital (U.S) 

Market Opportunities

  • Awareness about Digital Therapeutics
  • Focus on Early Intervention
  • Personalized medicine:

Market Definition

Disruptive behavior disorder is a disease that is very frequent among children. It can disrupt a child's day-to-day life. Children with disruptive behavior disorder depict a defiant behavior, exhibiting signs of short-temperedness, aggressiveness, arguments, fighting, stealing, and disobeying authority.

Global Disruptive Behavior Disorder Treatments Market Dynamics

Drivers

  • Growing Prevalence of DBD

The market for Disruptive Behavior Disorder Treatments is anticipated to grow significantly over the forecast period due to a number of key factors; the increasing prevalence of DBD among children and adolescents is one of the key drivers for the market. According to the Centers for Disease Control and Prevention (CDC), about 9.4% of children aged 2-17 years in the United States have been diagnosed with ADHD, one of the most common DBD.

  • Increasing Government Initiatives

The government's initiatives to improve mental health awareness and provide better access to mental health services are driving the growth of the DBD market. For instance, in 2020, the US government passed the Mental Health Access Improvement Act to improve access to mental health services for children and adolescents.

  • Rising Awareness and Diagnosis Rates:

The growing awareness about DBD and its impact on children's social, emotional, and academic lives is driving the demand for effective treatment options. The increasing diagnosis rates of DBD are also contributing to the growth of the market.

Opportunities

  • Awareness of Digital Therapeutics

The growing popularity of digital therapeutics, which involve the use of technology-based interventions to treat mental health disorders, presents an opportunity for the DBD treatment market. Digital therapeutics offer a non-pharmacological approach to treatment and can be delivered remotely, which can improve access to treatment options.

  • Focus on Early Intervention

The focus on early intervention and prevention of DBD presents an opportunity for the market. Early intervention can improve treatment outcomes and reduce the long-term impact of DBD on the patient's social, emotional, and academic life. This presents an opportunity for the development of new treatment options and the expansion of existing treatment options.

  • Personalized medicine:

The development of personalized medicine, which involves tailoring treatment based on the patient's genetic makeup and other individual characteristics, presents an opportunity for the DBD treatment market. Personalized medicine can improve treatment outcomes and reduce the risk of adverse effects.

Restraints/Challenges

The lack of consensus on the diagnosis and treatment of DBD, particularly in children and adolescents, limited insurance coverage for mental health services, including DBD treatment, is a major restraint for the market. Also, the stigma associated with mental illness, shortage of trained mental health professionals and delayed diagnosis are projected to challenge the market in the forecast period of 2023-2030.

This Disruptive Behavior Disorder Treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Disruptive Behavior Disorder Treatment market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

  • In 2020, FDA granted Breakthrough Therapy designation to Alkermes's ALKS 3831, a potential treatment for schizophrenia and bipolar disorder that are associated with DBD.
  • In 2019, Ironshore Pharmaceuticals received FDA approval for Jornay PM (methylphenidate) extended-release capsules for the treatment of ADHD which is closely related to DBD.

Global Disruptive Behavior Disorder Treatment Market Scope

The Disruptive Behavior Disorder Treatment market is segmented on the basis of type and treatment. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Conduct Disorder
  • Intermittent Explosive Disorder
  • Oppositional Defiant Disorder

Treatment

  • Social and Emotional Skills Training
  • Medication Management
  • Individual Therapy
  • Comprehensive Evaluation
  • Family Therapy
  • Group Therapy
  • Parenting Modification

Global Disruptive Behavior Disorder Treatment Market Regional Analysis/Insights

The global Disruptive Behavior Disorder Treatment market is analysed and market size insights and trends are provided by country, type and treatment as referenced above.

The countries covered in the Disruptive Behavior Disorder Treatment market report U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the Disruptive Behavior Disorder Treatment market because of the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people with rising neurological disorders.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for neurological disorder treatments and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Disruptive Behavior Disorder Treatment  Market Share Analysis

The Disruptive Behavior Disorder Treatment market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the Disruptive Behavior Disorder Treatment market.

Some of the major players operating in the Disruptive Behavior Disorder Treatment market are:

  • Lilly (U.S)
  • Pfizer Inc. (U.S)
  • Johnson & Johnson Services, Inc. (U.S)
  • Bionomics (Australia)
  • Highland Ridge Hospital (U.S)
  • Lakeview Health (U.S)
  • Boston Children's Hospital (U.S)
  • Integris Health (U.S)
  • ST. JOHN (U.K)
  • Springwoods Behavioral Health. (Arkansas)
  • Alliance Health Durant (U.S)
  • Midwest Health Center (U.S)
  • Chelsea Therapeutics International, Ltd. (U.S)
  • DURECT CORPORATION (U.S)
  • Jane Phillips Medical Center (U.S)
  • KVC Health System (U.S)
  • Mindsbhumika (India)
  • NYU Langone Hospitals (U.S)
  • Seattle Children's Hospital (U.S)

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

O mercado é segmentado com base em , By Type (Conduct Disorder, Intermittent Explosive Disorder, Oppositional Defiant Disorder), Treatment (Social and Emotional Skills Training, Medication Management, Individual Therapy, Comprehensive Evaluation, Family Therapy, Group Therapy, Parenting Modification) – Industry Trends and Forecast to 2030. .
O tamanho do Global Disruptive Behavior Disorder Treatment Market foi avaliado em USD 1381.06 USD Million no ano de 2022.
O Global Disruptive Behavior Disorder Treatment Market está projetado para crescer a um CAGR de 5.3% durante o período de previsão de 2023 a 2030.
Os principais players do mercado incluem ,Lilly Pfizer Inc. Johnson &amp, Johnson ServicesInc. Bionomics Highland Ridge Hospital Lakeview Health Boston Children&#39,s Hospital Integris Health ST. JOHN Springwoods Behavioral Health. Alliance Health Durant Midwest Health Center Chelsea Therapeutics InternationalLtd. DURECT CORPORATION Jane Phillips Medical Center KVC Health System Mindsbhumika NYU Langone Hospitals Seattle Children&#39,s Hospital ,.
O relatório de mercado cobre dados de U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa.
Testimonial